Search research articles
Contact Us
Filters
Showing results (1-10 of 2,568) with videos related to
Page
of 257
Sort By:
Oncology
|
January 1, 1989
Anticancer potential of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma in comparison with chemical immunomodulators and on cyclosporine-accelerated AKR leukemia
E Furusawa, S Furusawa
Cancer Letters
|
April 9, 1990
Antitumor potential of low-dose chemotherapy manifested in combination with immunotherapy of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma
E Furusawa, S Furusawa
Oncology
|
January 1, 1988
Effect of pretazettine and viva-natural, a dietary seaweed extract, on spontaneous AKR leukemia in comparison with standard drugs
E Furusawa, S Furusawa
Oncology
|
January 1, 1985
Anticancer activity of a natural product, viva-natural, extracted from Undaria pinnantifida on intraperitoneally implanted Lewis lung carcinoma
E Furusawa, S Furusawa
Chemotherapy
|
January 1, 1986
Therapeutic potentials of pretazettine, standard anticancer drugs, and combinations on subcutaneously implanted Lewis lung carcinoma
E Furusawa, S Furusawa
Chemotherapy
|
January 1, 1985
Adverse effect of cyclophosphamide at moderate dose in combination with standard drugs on intraperitoneally implanted Lewis lung carcinoma in mice
E Furusawa, S Furusawa
Proceedings of the Western Pharmacology Society
|
January 1, 1981
Toxicity of pretazettine in rats and cats
R Lockwood, E Furusawa, S Furusawa
Chemotherapy
|
January 1, 1983
Therapeutic activity of pretazettine, standard drugs, and the combinations on intraperitoneally implanted Lewis lung carcinoma in mice
E Furusawa, E Furusawa, L Sokugawa
Proceedings of the Western Pharmacology Society
|
January 1, 1975
Antiviral-anticancer activity of tobacco leaf and the smoke condensate
E Furusawa, S Furusawa, J Y Lee
Chemotherapy
|
January 1, 1981
Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen
E Furusawa, M K Lum, S Furusawa
Page
of 257
Search research articles
Search
Showing results (1-10 of 2,568) with videos related to
Sort By:
Page
of 257
Oncology
|
January 1, 1989
Anticancer potential of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma in comparison with chemical immunomodulators and on cyclosporine-accelerated AKR leukemia
E Furusawa, S Furusawa
Cancer Letters
|
April 9, 1990
Antitumor potential of low-dose chemotherapy manifested in combination with immunotherapy of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma
E Furusawa, S Furusawa
Oncology
|
January 1, 1988
Effect of pretazettine and viva-natural, a dietary seaweed extract, on spontaneous AKR leukemia in comparison with standard drugs
E Furusawa, S Furusawa
Oncology
|
January 1, 1985
Anticancer activity of a natural product, viva-natural, extracted from Undaria pinnantifida on intraperitoneally implanted Lewis lung carcinoma
E Furusawa, S Furusawa
Chemotherapy
|
January 1, 1986
Therapeutic potentials of pretazettine, standard anticancer drugs, and combinations on subcutaneously implanted Lewis lung carcinoma
E Furusawa, S Furusawa
Chemotherapy
|
January 1, 1985
Adverse effect of cyclophosphamide at moderate dose in combination with standard drugs on intraperitoneally implanted Lewis lung carcinoma in mice
E Furusawa, S Furusawa
Proceedings of the Western Pharmacology Society
|
January 1, 1981
Toxicity of pretazettine in rats and cats
R Lockwood, E Furusawa, S Furusawa
Chemotherapy
|
January 1, 1983
Therapeutic activity of pretazettine, standard drugs, and the combinations on intraperitoneally implanted Lewis lung carcinoma in mice
E Furusawa, E Furusawa, L Sokugawa
Proceedings of the Western Pharmacology Society
|
January 1, 1975
Antiviral-anticancer activity of tobacco leaf and the smoke condensate
E Furusawa, S Furusawa, J Y Lee
Chemotherapy
|
January 1, 1981
Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen
E Furusawa, M K Lum, S Furusawa
Page
of 257